# Exhibit Review — Gemini 3 Flash (Round 1)

**Role:** Visual exhibit advisor
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-10T14:52:34.748778
**Route:** Direct Google API + PDF
**Tokens:** 17877 in / 2029 out
**Response SHA256:** 9644c11e2aeb309c

---

As a visual exhibit advisor for top-tier economics journals, I have reviewed the paper "The Symmetric Test: Drug Decriminalization and Recriminalization in Oregon." The paper utilizes a novel "symmetric" synthetic control design. While the core analysis is sophisticated, the visual presentation requires refinement to meet the standards of the *AER* or *QJE*.

---

# Exhibit-by-Exhibit Review

## Main Text Exhibits

### Table 1: "Summary Statistics: Drug Overdose Death Rates by Phase"
**Page:** 8
- **Formatting:** Needs professional "Booktabs" style. The vertical line in the header is a major violation of journal style. Alignment is inconsistent.
- **Clarity:** Good logical flow, though the "Others" rows are a bit crowded.
- **Storytelling:** Essential. It establishes the "Oregon vs. Others" baseline that justifies the SCM.
- **Labeling:** Clear.
- **Recommendation:** **REVISE**
  - Remove all vertical lines.
  - Use `\toprule`, `\midrule`, and `\bottomrule`.
  - Decimal-align all numbers using `dcolumn` or `siunitx` (e.g., 0.332 should align with 13.0).
  - Add a note defining "SD" (Standard Deviation).

### Figure 1: "Design 1: Oregon vs. Synthetic Oregon (Decriminalization)"
**Page:** 12
- **Formatting:** Clean "ggplot2" style, but fonts are too small for a 1-column print.
- **Clarity:** The message is clear—Oregon diverges post-2021.
- **Storytelling:** Central exhibit. However, it is slightly redundant with Figure 2.
- **Labeling:** "Measure 110" text is a bit small.
- **Recommendation:** **KEEP AS-IS** (with minor font size increase).

### Figure 2: "Design 1: Treatment Effect Over Time (Gap Plot)"
**Page:** 13
- **Formatting:** Standard SCM gap plot.
- **Clarity:** Very high.
- **Storytelling:** This is more effective than Figure 1 for showing the "inverted U" shape discussed in the text.
- **Labeling:** Good.
- **Recommendation:** **REVISE**
  - **Consolidation:** Consider making Figure 1 and Figure 2 Panels A and B of a single "Figure 1: Main Decriminalization Results." This is standard top-journal practice to save space and link the raw data to the gap.

### Table 2: "Synthetic Control Weights: Design 1 (Top Donors)"
**Page:** 14
- **Formatting:** Clean but simple.
- **Clarity:** High.
- **Storytelling:** Essential for SCM transparency. 
- **Labeling:** "Other states (n=41)" is a good way to handle the tail.
- **Recommendation:** **KEEP AS-IS**

### Figure 3: "Permutation Inference: Design 1"
**Page:** 15
- **Formatting:** The red line is distinct. Histogram bins are appropriate.
- **Clarity:** Clearly shows Oregon as an outlier.
- **Storytelling:** Strong evidence for the p-value.
- **Labeling:** Y-axis "Count" is fine, but "Frequency" is more standard.
- **Recommendation:** **KEEP AS-IS**

### Figure 4: "Design 2: Oregon vs. Synthetic Oregon (Recriminalization)"
**Page:** 16
- **Formatting:** Similar to Figure 1.
- **Clarity:** The short post-treatment window (2025) makes the divergence look "squished."
- **Storytelling:** Necessary for the second half of the symmetric test.
- **Labeling:** Good.
- **Recommendation:** **REVISE**
  - Like Design 1, merge this with its corresponding gap plot (currently Figure 5) into a single 2-panel figure.

### Table 3: "Main Results: Synthetic Control Estimates"
**Page:** 17
- **Formatting:** Vertical lines must be removed. Parentheses around Standard Errors are good.
- **Clarity:** Excellent summary of the whole paper.
- **Storytelling:** This is the "Money Table." It should probably be moved earlier or highlighted more.
- **Labeling:** Significance stars (*, **, ***) are defined but not used in the table—apply them to the ATT column.
- **Recommendation:** **REVISE**
  - Add significance stars based on the p-values shown.
  - Decimal-align the columns.
  - Remove the internal vertical lines.

### Figure 5: "The Symmetric Test: Combined Gap Plots from Both Designs"
**Page:** 18
- **Formatting:** The over-plotting of the blue line on the red line is slightly confusing where they overlap in the pre-treatment period.
- **Clarity:** This is the most complex figure. The "mirror image" message is the goal.
- **Storytelling:** High impact. It visualizes the core "Symmetric Test" thesis.
- **Labeling:** Vertical dotted lines need clearer labels (Treatment 1 vs Treatment 2).
- **Recommendation:** **REVISE**
  - Use a slightly thinner line weight for the "Recriminalization" (blue) line so it doesn't totally obscure the "Decriminalization" (red) line in the 2021–2024 window.

### Table 4: "Drug Decomposition: Decriminalization Effect by Drug Category"
**Page:** 19
- **Formatting:** Clean.
- **Clarity:** High.
- **Storytelling:** Vital for the "Interpretation B" (fentanyl confound) argument.
- **Labeling:** Good.
- **Recommendation:** **KEEP AS-IS**

### Figure 6: "Drug-Specific Decomposition of the Decriminalization Effect"
**Page:** 20
- **Formatting:** Color coding is inconsistent with previous plots (using red/blue for something other than policy switches).
- **Clarity:** The bar chart is a bit "heavy."
- **Storytelling:** Redundant with Table 4. 
- **Recommendation:** **REMOVE** (The table conveys the precision—SEs/p-values—much better than the bars. Top journals prefer the table for coefficients).

### Figure 7: "Fentanyl Exposure: Oregon vs. National Average"
**Page:** 21
- **Formatting:** Clean.
- **Clarity:** High.
- **Storytelling:** Crucial "smoking gun" for the confounder argument. It shows the "catch-up" effect.
- **Recommendation:** **KEEP AS-IS**

---

## Appendix Exhibits

### Table 5: "Robustness: Design 1 Under Alternative Specifications"
**Page:** 30
- **Formatting:** Needs same Booktabs overhaul as Table 1.
- **Recommendation:** **KEEP IN APPENDIX** but fix formatting.

### Figure 8: "Oregon vs. National Average Overdose Rate"
**Page:** 31
- **Formatting:** The shaded IQR is excellent. The break in the line at 2021 is confusing—why is there a gap?
- **Recommendation:** **REVISE**
  - Remove the white-space gap in the data lines if the data is continuous.
  - **PROMOTE TO MAIN TEXT:** This "Raw Data" plot often builds more trust than the SCM. Move this to Section 3.3 (Summary Stats).

### Table 6: "Standardized Effect Sizes for Main Outcomes"
**Page:** 32
- **Recommendation:** **REMOVE** (This feels like "meta-analysis" filler. The raw ATTs in Table 3 and 4 are sufficient for an economics audience).

---

## Overall Assessment

- **Exhibit count:** 4 Main Tables, 7 Main Figures, 2 Appendix Tables, 1 Appendix Figure.
- **General quality:** High analytical quality, but "over-figured." Several figures (1, 2, 4, 5) cover the same ground.
- **Strongest exhibits:** Table 3 (Main Results) and Figure 5 (Combined Gaps).
- **Weakest exhibits:** Figure 6 (redundant) and Figure 8 (formatting issues).
- **Missing exhibits:** A **"Donor Weights Map"** or a list of weights for Design 2 (to see if the counterfactual changed significantly from Design 1).

### Top 3 Improvements:
1. **Consolidate SCM Visuals:** Create two "Mega-Figures." Figure 1 should be a 2-panel plot (Panel A: Raw/Synthetic levels; Panel B: Gaps) for the **Decriminalization** result. Figure 2 should be the same for **Recriminalization**.
2. **Professional Table Formatting:** Eliminate all vertical lines and double borders. Use the `booktabs` LaTeX package style. Decimal-align all numerical columns.
3. **Streamline the Narrative:** Remove Figure 6 (Bar chart) as Table 4 is more precise. Move Figure 8 (Raw data with IQR) to the main text to establish the "Oregon vs. US" trend before showing the SCM results.